Celltrion’Recyrona’ obtained recommendations for use by country for all product approvals from the European Medicines Agency
[김창수의 e뉴스 브리핑] Yuhan Corporation to invest 10 billion won in April Bio… 2nd major shareholder registration, etc.
JW Choongwae Pharmaceutical proves the effect of improving lipids in phase 3 clinical trials of ribarojet
Financial Supervisory Service to close dispute settlement in the first half of the five major private equity funds